U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07941024) titled 'H.A.L.T. MAX Spectacle Lenses for High Myopia Control' on Oct. 29.
Brief Summary: This study is intended to focus on children aged 7-14 years with high myopia and to use a 2-year, single-arm, prospective design in which participants wear H.A.L.T. MAX lenses for at least 12 hours per day for 2 consecutive years. By comparing changes in refractive error and other indicators, the study will evaluate the efficacy, safety, and wearing compliance of H.A.L.T. MAX lenses in delaying myopia progression in children with high myopia, thereby providing scientific evidence for public health efforts to delay myopia progression in highly myopic po...